Bis[tri(i-propyl)cyclopentadienyl]barium, 98 %
CAS: 147658-83-1
Formula: BaC28H46

Product details

Description
Name: Bis[tri(i-propyl)cyclopentadienyl]barium, 98 %
CAS: 147658-83-1
Formula: BaC28H46
Structure: Ba[(i-C3H7)3C5H2]2

Product Properties: Purity: min. 97,5% (by elemental analysis)
Appearance: orange viscous liq. or yellow solid  
NMR H1: conforms to structure
Elemental analysis: % C = 63,05-66,29; % H = 8,70-9,14 %

CAS

147658-83-1

Formula

BaC28H46

Order code

EO02342

Important information about Bis[tri(i-propyl)cyclopentadienyl]barium, 98 % - CAS:147658-83-1

The above information and Specification of the product CAS:147658-83-1 shall be used only as a guide. If you wish higher quality of the product with formula BaC28H46, special packing or have any other requirements, please contact us.

Intatrade Chemicals concentrated its efforts on research and development of new synthetic technologies and on satisfying consumer demand for new synthetic materials.

We offer wide-range services for custom synthesis to meet various requirements of customers targeted applications.



Formula: BaC28H46 - (BaC28H46)


CAS: 12131-66-7

Tris(3-hexyne)tungsten(0) carbonyl, 98+%
Formula: (C6H10)3(CO)W

CAS: 1317-34-6

Manganese(III) oxide
Formula: Mn2O3

CAS: 220000-87-3

4-Chloro-Pyridine-2-Carboxylic Acid Methylamide
Formula: C7H7ClN2O

CAS: 17814-85-6

(4-Carboxybutyl)-triphenylphosphomum bromide
Formula: C23H24BrO2P

CAS: 65816-20-8

N-(Ethoxycarbonylphenyl)-N-Ethyl-N-Phenyl Formamidine
Formula: C18H20N2O2

CAS: 761446-44-0

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Formula: C10H17BN2O2

CAS: 1206-46-8

Trimethyl(pentafluorophenyl)silane
Formula: C9H9F5Si

CAS: 10373-78-1

DL-Camphorquinone
Formula: C10H14O2

CAS: 98-96-4

Pyrazinamide
Formula: C5H5N3O

CAS: 50-79-3

2,5-Dichlorobenzoic acid, 98+%
Formula: C7H4Cl2O2

Address

Intatrade Chemicals GmbH
Am Winkel 5
06774 Muldestausee, Germany

Contacts

Email: es@intatrade.de
Tel.:
+49 34955/406944 /45
Fax: +49 34955/406946
WhatsApp

CONTACT US